Table of Contents Author Guidelines Submit a Manuscript
TheScientificWorldJOURNAL
Volume 6, Pages 1911-1922
http://dx.doi.org/10.1100/tsw.2006.319
Review Article

DYRK1A (Dual-Specificity Tyrosine-Phosphorylated and -Regulated Kinase 1A): A Gene with Dosage Effect During Development and Neurogenesis

Genes and Disease Program, Genomic Regulation Center, Barcelona Biomedical Research Park, 08003 Barcelona, Spain

Received 6 March 2006; Accepted 6 May 2006

Academic Editor: Yann Hérault

Copyright © 2006 M. Dierssen and M. Martínez de Lagrán.

Citations to this Article [59 citations]

The following is the list of published articles that have cited the current article.

  • Ariadna Laguna, Sergi Aranda, Maria Jose Barallobre, Rima Barhoum, Eduardo Fernandez, Vassiliki Fotaki, Jean Maurice Delabar, Susana de la Luna, Pedro de la Villa, and Maria L. Arbones, “The Protein Kinase DYRK1A Regulates Caspase-9-Mediated Apoptosis during Retina Development,” Developmental Cell, vol. 15, no. 6, pp. 841–853, 2008. View at Publisher · View at Google Scholar
  • María Martínez de Lagrán, Analía Bortolozzi, Juan Gispert, Olga Millán, Francesc Artigas, Cristina Fillat, and Maria del Mar Dierssen, “El envejecimiento en el síndrome de Down: Dyrk1A como gen candidato para el declive cognitivo,” Revista Médica Internacional sobre el Síndrome de Down, vol. 12, no. 3, pp. 34–40, 2008. View at Publisher · View at Google Scholar
  • María Martínez de Lagrán, Analía Bortolozzi, Juan Gispert, Olga Millán, Francesc Artigas, Cristina Fillat, and Maria del Mar Dierssen, “Ageing in Down Syndrome: DYRK1A As a Candidate Gene for Cognitive Decline,” International Medical Review on Down Syndrome, vol. 12, no. 3, pp. 34–40, 2008. View at Publisher · View at Google Scholar
  • Jon Ortiz-Abalia, Ignasi Sahún, Xavier Altafaj, Núria Andreu, Xavier Estivill, Mara Dierssen, and Cristina Fillat, “Targeting Dyrk1A with AAVshRNA Attenuates Motor Alterations in TgDyrk1A, a Mouse Model of Down Syndrome,” The American Journal of Human Genetics, vol. 83, no. 4, pp. 479–488, 2008. View at Publisher · View at Google Scholar
  • Sergi Aranda, Monica Alvarez, Silvia Turro, Ariadna Laguna, and Susana de la Luna, “Sprouty2-mediated inhibition of fibroblast growth factor signaling is modulated by the protein kinase DYRK1A,” Molecular And Cellular Biology, vol. 28, no. 19, pp. 5899–5911, 2008. View at Publisher · View at Google Scholar
  • Yuh-Jin Liang, Hung-Shu Chang, Chen-Yu Wang, and Winston C. Y. Yu, “DYRK1A stabilizes HPV16E7 oncoprotein through phosphorylation of the threonine 5 and threonine 7 residues,” International Journal Of Biochemistry & Cell Biology, vol. 40, no. 11, pp. 2431–2441, 2008. View at Publisher · View at Google Scholar
  • Pisca Liberali, Pauli Ramo, and Lucas Pelkmans, “Protein Kinases: Starting a Molecular Systems View of Endocytosis,” Annual Review of Cell and Developmental Biology, vol. 24, pp. 501–523, 2008. View at Publisher · View at Google Scholar
  • Mara Dierssen, Yann Herault, and Xavier Estivill, “Aneuploidy: From a Physiological Mechanism of Variance to Down Syndrome,” Physiological Reviews, vol. 89, no. 3, pp. 887–920, 2009. View at Publisher · View at Google Scholar
  • Gab Seok Kim, Joo Eun Jung, Kuniyasu Niizuma, and Pak H. Chan, “CK2 Is a Novel Negative Regulator of NADPH Oxidase and a Neuroprotectant in Mice after Cerebral Ischemia,” Journal Of Neuroscience, vol. 29, no. 47, pp. 14779–14789, 2009. View at Publisher · View at Google Scholar
  • Gloria Arque, Maria Martinez de Lagran, Maria L. Arbones, and Mara Dierssen, “Age-associated motor and visuo-spatial learning phenotype in Dyrk1A heterozygous mutant mice,” Neurobiology Of Disease, vol. 36, no. 2, pp. 312–319, 2009. View at Publisher · View at Google Scholar
  • Nora Göckler, Guillermo Jofre, Chrisovalantis Papadopoulos, Ulf Soppa, Francisco J. Tejedor, and Walter Becker, “Harmine specifically inhibits protein kinase DYRK1A and interferes with neurite formation,” FEBS Journal, vol. 276, no. 21, pp. 6324–6337, 2009. View at Publisher · View at Google Scholar
  • Ira T Lott, and Mara Dierssen, “Cognitive deficits and associated neurological complications in individuals with Down's syndrome,” The Lancet Neurology, vol. 9, no. 6, pp. 623–633, 2010. View at Publisher · View at Google Scholar
  • Eva Lilienthal, Katharina Kolanowski, and Walter Becker, “Development of a sensitive non-radioactive protein kinase assay and its application for detecting DYRK activity in Xenopus laevis oocytes,” Bmc Biochemistry, vol. 11, 2010. View at Publisher · View at Google Scholar
  • Hideki Fujita, Chiharu Torii, Rika Kosaki, Shinya Yamaguchi, Jun Kudoh, Kumiko Hayashi, Takao Takahashi, and Kenjiro Kosaki, “Microdeletion of the Down Syndrome Critical Region at 21q22,” American Journal of Medical Genetics Part A, vol. 152A, no. 4, pp. 950–953, 2010. View at Publisher · View at Google Scholar
  • Francisco J. Tejedor, and Barbara Hämmerle, “MNB/DYRK1A as a multiple regulator of neuronal development,” FEBS Journal, vol. 278, no. 2, pp. 223–235, 2010. View at Publisher · View at Google Scholar
  • Walter Becker, and Wolfgang Sippl, “Activation, regulation, and inhibition of DYRK1A,” FEBS Journal, vol. 278, no. 2, pp. 246–256, 2010. View at Publisher · View at Google Scholar
  • Debra Toiber, Garikoitz Azkona, Shani Ben-Ari, Nuria Toran, Hermona Soreq, and Mara Dierssen, “Engineering DYRK1A overdosage yields Down syndrome-characteristic cortical splicing aberrations,” Neurobiology Of Disease, vol. 40, no. 1, pp. 348–359, 2010. View at Publisher · View at Google Scholar
  • Barbara Haemmerle, Edgar Ulin, Jordi Guimera, Walter Becker, Francois Guillemot, and Francisco J. Tejedor, “Transient expression of Mnb/Dyrk1a couples cell cycle exit and differentiation of neuronal precursors by inducing p27(KIP1) expression and suppressing NOTCH signaling,” Development, vol. 138, no. 12, pp. 2543–2554, 2011. View at Publisher · View at Google Scholar
  • Mireia Vilardell, Axel Rasche, Anja Thormann, Elisabeth Maschke-Dutz, Luis A. Perez-Jurado, Hans Lehrach, and Ralf Herwig, “Meta-analysis of heterogeneous Down Syndrome data reveals consistent genome-wide dosage effects related to neurological processes,” Bmc Genomics, vol. 12, 2011. View at Publisher · View at Google Scholar
  • Bwm van Bon, A Hoischen, J Hehir-Kwa, Apm de Brouwer, C Ruivenkamp, Acj Gijsbers, Cl Marcelis, N de Leeuw, Ja Veltman, Hg Brunner, and Bba de Vries, “Intragenic deletion in DYRK1A leads to mental retardation and primary microcephaly,” Clinical Genetics, vol. 79, no. 3, pp. 296–299, 2011. View at Publisher · View at Google Scholar
  • Sebastiaan M. Bol, Perry D. Moerland, Sophie Limou, Yvonne van Remmerden, Cedric Coulonges, Danielle van Manen, Joshua T. Herbeck, Jacques Fellay, Margit Sieberer, Jantine G. Sietzema, Ruben van't Slot, Jeremy Martinson, Jean-Francois Zagury, Hanneke Schuitemaker, and Angelique B. van't Wout, “Genome-Wide Association Study Identifies Single Nucleotide Polymorphism in DYRK1A Associated with Replication of HIV-1 in Monocyte-Derived Macrophages,” Plos One, vol. 6, no. 2, 2011. View at Publisher · View at Google Scholar
  • Hyoung Kyoung Choi, and Kwang Chul Chung, “Dyrk1A Positively Stimulates ASK1-JNK Signaling Pathway during Apoptotic Cell Death,” Experimental Neurobiology, vol. 20, no. 1, pp. 35, 2011. View at Publisher · View at Google Scholar
  • Asma Tlili, Alexander Hoischen, Clémentine Ripoll, Eva Benabou, Anne Badel, Anne Ronan, Renaud Touraine, Yann Grattau, Samantha Stora, Bregje Bon, Bert Vries, Björn Menten, Nele Bockaert, Joseph Gecz, Stylianos E. Antonarakis, Dominique Campion, Marie-Claude Potier, Henri Bléhaut, Jean-Maurice Delabar, and Nathalie Janel, “BDNF and DYRK1A Are Variable and Inversely Correlated in Lymphoblastoid Cell Lines from Down Syndrome Patients,” Molecular Neurobiology, vol. 46, no. 2, pp. 297–303, 2012. View at Publisher · View at Google Scholar
  • Vaishali A. Kulkarni, and Bonnie L. Firestein, “The dendritic tree and brain disorders,” Molecular and Cellular Neuroscience, vol. 50, no. 1, pp. 10–20, 2012. View at Publisher · View at Google Scholar
  • Christophe Noll, Asma Tlili, Clémentine Ripoll, Ludovic Mallet, Jean-Louis Paul, Jean-Maurice Delabar, and Nathalie Janel, “Dyrk1a activates antioxidant NQO1 expression through an ERK1/2–Nrf2 dependent mechanism,” Molecular Genetics and Metabolism, vol. 105, no. 3, pp. 484–488, 2012. View at Publisher · View at Google Scholar
  • Tarik F. Haydar, and Roger H. Reeves, “Trisomy 21 and early brain development,” Trends in Neurosciences, vol. 35, no. 2, pp. 81–91, 2012. View at Publisher · View at Google Scholar
  • Breland Smith, Federico Medda, Vijay Gokhale, Travis Dunckley, and Christopher Hulme, “Recent Advances in the Design, Synthesis, and Biological Evaluation of Selective DYRK1A Inhibitors: A New Avenue for a Disease Modifying Treatment of Alzheimer’s?,” ACS Chemical Neuroscience, vol. 3, no. 11, pp. 857–872, 2012. View at Publisher · View at Google Scholar
  • Mara Dierssen, “Down syndrome: the brain in trisomic mode,” Nature Reviews Neuroscience, vol. 13, no. 12, pp. 844–858, 2012. View at Publisher · View at Google Scholar
  • Bozena Mazur-Kolecka, Adam Golabek, Elizabeth Kida, Ausma Rabe, Yu-Wen Hwang, Tatyana Adayev, Jerzy Wegiel, Michael Flory, Wojciech Kaczmarski, Elaine Marchi, and Janusz Frackowiak, “Effect of DYRK1A activity inhibition on development of neuronal progenitors isolated from Ts65Dn mice,” Journal of Neuroscience Research, vol. 90, no. 5, pp. 999–1010, 2012. View at Publisher · View at Google Scholar
  • M. Martinez de Lagran, R. Benavides-Piccione, I. Ballesteros-Yanez, M. Calvo, M. Morales, C. Fillat, J. DeFelipe, G. J. A. Ramakers, and M. Dierssen, “Dyrk1A Influences Neuronal Morphogenesis Through Regulation of Cytoskeletal Dynamics in Mammalian Cortical Neurons,” Cerebral Cortex, vol. 22, no. 12, pp. 2867–2877, 2012. View at Publisher · View at Google Scholar
  • Ira T. Lott, “Neurological phenotypes for Down syndrome across the life span,” Down Syndrome: From Understanding the Neurobiology to Therapy, vol. 197, pp. 101–121, 2012. View at Publisher · View at Google Scholar
  • A.M. Kleschevnikov, P.V. Belichenko, A. Salehi, and C. Wu, “Discoveries in Down syndrome,” Down Syndrome: From Understanding the Neurobiology to Therapy, vol. 197, pp. 199–221, 2012. View at Publisher · View at Google Scholar
  • Mara Dierssen, “A commentary on: Overexpression of Dyrk1A inhibits choline acetyltransferase induction by oleic acid in cellular models of Down syndrome,” Experimental Neurology, vol. 247, pp. 110–112, 2013. View at Publisher · View at Google Scholar
  • Meritxell Pons-Espinal, Maria Martinez de Lagran, and Mara Dierssen, “Environmental enrichment rescues Dyrk1A activity and hippocampal adult neurogenesis in TgDyrk1A,” Neurobiology of Disease, 2013. View at Publisher · View at Google Scholar
  • Meritxell Pons-Espinal, Maria Martinez Lagran, and Mara Dierssen, “Functional implications of hippocampal adult neurogenesis in intellectual disabilities,” Amino Acids, vol. 45, no. 1, pp. 113–131, 2013. View at Publisher · View at Google Scholar
  • Carlos Bessa, Patrícia Maciel, and Ana João Rodrigues, “Using C. elegans to Decipher the Cellular and Molecular Mechanisms Underlying Neurodevelopmental Disorders,” Molecular Neurobiology, 2013. View at Publisher · View at Google Scholar
  • Maruan Hijazi, Cristina Fillat, José M. Medina, and Ana Velasco, “Overexpression of DYRK1A inhibits choline acetyltransferase induction by oleic acid in cellular models of Down syndrome,” Experimental Neurology, vol. 239, pp. 229–234, 2013. View at Publisher · View at Google Scholar
  • Federico Medda, Breland Smith, Vijay Gokhale, Arthur Y. Shaw, Travis Dunckley, Christopher Hulme, Federico Medda, Breland Smith, Vijay Gokhale, Arthur Y. Shaw, Travis Dunckley, and Christopher Hulme, “Beyond Secretases: Kinase Inhibitors for the Treatment of Alzheimer's Disease,” Annual Reports in Medicinal Chemistry, Vol 48, vol. 48, pp. 57–71, 2013. View at Publisher · View at Google Scholar
  • Gaia Elena Berto, Cristina Iobbi, Paola Camera, Elena Scarpa, Corinne Iampietro, Federico Bianchi, Marta Gai, Francesco Sgro, Flavio Cristofani, Annette Gaertner, Carlos G. Dotti, and Ferdinando Di Cunto, “The DCR Protein TTC3 Affects Differentiation and Golgi Compactness in Neurons through Specific Actin-Regulating Pathways,” Plos One, vol. 9, no. 4, 2014. View at Publisher · View at Google Scholar
  • Pavel Karpov, Aleksey Raevsky, Maxim Korablyov, and Yaroslav Blume, “Identification of Plant Homologues of Dual Specificity Yak1-Related Kinases,” Computational Biology Journal, vol. 2014, pp. 1–14, 2014. View at Publisher · View at Google Scholar
  • Nana Jin, Xiaomin Yin, Jianlan Gu, Xinhua Zhang, Jianhua Shi, Wei Qian, Yuhua Ji, Maohong Cao, Xiaosong Gu, Fei Ding, Khalid Iqbal, Cheng-Xin Gong, and Fei Liu, “Truncation and Activation of Dual Specificity Tyrosine Phosphorylation-regulated Kinase 1A by Calpain I A MOLECULAR MECHANISM LINKED TO TAU PATHOLOGY ,” Journal Of Biological Chemistry, vol. 290, no. 24, pp. 15219–15237, 2015. View at Publisher · View at Google Scholar
  • Jianling Ji, Hane Lee, Bob Argiropoulos, Naghmeh Dorrani, John Mann, Julian A Martinez-Agosto, Natalia Gomez-Ospina, Natalie Gallant, Jonathan A Bernstein, Louanne Hudgins, Leah Slattery, Bertrand Isidor, Cédric Le Caignec, Albert David, Ewa Obersztyn, Barbara Wiśniowiecka-Kowalnik, Michelle Fox, Joshua L Deignan, Eric Vilain, Emily Hendricks, Margaret Horton Harr, Sarah E Noon, Jessi R Jackson, Alisha Wilkens, Ghayda Mirzaa, Noriko Salamon, Jeff Abramson, Elaine H Zackai, Ian Krantz, A Micheil Innes, Stanley F Nelson, Wayne W Grody, and Fabiola Quintero-Rivera, “DYRK1A haploinsufficiency causes a new recognizable syndrome with microcephaly, intellectual disability, speech impairment, and distinct facies,” European Journal of Human Genetics, 2015. View at Publisher · View at Google Scholar
  • Dulanjalee Kariyawasam, Latif Rachdi, Aurore Carre, Merce Martin, Marine Houlier, Nathalie Janel, Jean-Maurice Delabar, Raphael Scharfmann, and Michel Polak, “DYRK1A BAC Transgenic Mouse: A New Model of Thyroid Dysgenesis in Down Syndrome,” Endocrinology, vol. 156, no. 3, pp. 1171–1180, 2015. View at Publisher · View at Google Scholar
  • B W M van Bon, B P Coe, R Bernier, C Green, J Gerdts, K Witherspoon, T Kleefstra, M H Willemsen, R Kumar, P Bosco, M Fichera, D Li, D Amaral, F Cristofoli, H Peeters, E Haan, C Romano, H C Mefford, I Scheffer, J Gecz, B B A de Vries, and E E Eichler, “Disruptive de novo mutations of DYRK1A lead to a syndromic form of autism and ID,” Molecular Psychiatry, 2015. View at Publisher · View at Google Scholar
  • Thijs Booiman, Vladimir V. Loukachov, Karel A. van Dort, Angelique B. van 't Wout, and Neeltje A. Kootstra, “DYRK1A Controls HIV-1 Replication at a Transcriptional Level in an NFAT Dependent Manner,” Plos One, vol. 10, no. 12, 2015. View at Publisher · View at Google Scholar
  • P Fernández-Martínez, C Zahonero, and P Sánchez-Gómez, “DYRK1A: the double-edged kinase as a protagonist in cell growth and tumorigenesis,” Molecular & Cellular Oncology, vol. 2, no. 1, pp. e970048, 2015. View at Publisher · View at Google Scholar
  • Lyse Ruaud, Cyril Mignot, Agnès Guët, Christelle Ohl, Caroline Nava, Delphine Héron, Boris Keren, Christel Depienne, Valérie Benoit, Isabelle Maystadt, Damien Lederer, Daniel Amsallem, and Juliette Piard, “DYRK1A mutations in two unrelated patients,” European Journal of Medical Genetics, 2015. View at Publisher · View at Google Scholar
  • Christophe Labrière, Olivier Lozach, Mélina Blairvacq, Laurent Meijer, and Catherine Guillou, “Further investigation of Paprotrain: Towards the conception of selective and multi-targeted CNS kinase inhibitors,” European Journal of Medicinal Chemistry, 2016. View at Publisher · View at Google Scholar
  • Hyeongki Kim, Woo-Joo Song, Kweon Yu, Sungchan Cho, Kyu-Sun Lee, Ae-Kyeong Kim, Mingu Kang, Seung-Wook Chi, Jeong-Soo Lee, So-Young Lee, Miri Choi, Kwangman Choi, and Min-Sung Lee, “A chemical with proven clinical safety rescues down-syndromerelated phenotypes in through DYRK1A inhibition,” DMM Disease Models and Mechanisms, vol. 9, no. 8, pp. 839–848, 2016. View at Publisher · View at Google Scholar
  • Arnaud Duchon, and Yann Herault, “DYRK1A, a Dosage-Sensitive Gene Involved in Neurodevelopmental Disorders, Is a Target for Drug Development in Down Syndrome,” Frontiers in Behavioral Neuroscience, vol. 10, 2016. View at Publisher · View at Google Scholar
  • Silvia Stotani, Fabrizio Giordanetto, and Federico Medda, “DYRK1A inhibition as potential treatment for Alzheimer’s disease,” Future Medicinal Chemistry, 2016. View at Publisher · View at Google Scholar
  • Daniela Valenti, Lidia de Bari, Domenico de Rasmo, Anna Signorile, Alexandra Henrion-Caude, Andrea Contestabile, and Rosa Anna Vacca, “The polyphenols resveratrol and epigallocatechin-3-gallate restore the severe impairment of mitochondria in hippocampal progenitor cells from a down syndrome mouse model,” Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 2016. View at Publisher · View at Google Scholar
  • Yu Tang, Na Liu, Heng Liu, Pin Wang, Xiulian Sun, Qiang Liu, Long Chen, and Fangfang Lang, “E3 ligase SCFβTrCP-induced DYRK1A protein degradation is essential for cell cycle progression in HEK293 cells,” Journal of Biological Chemistry, vol. 291, no. 51, pp. 26399–26409, 2016. View at Publisher · View at Google Scholar
  • E. Sacide Çağlayan, “ Generation of improved human cerebral organoids from single copy DYRK1A knockout induced pluripotent stem cells in trisomy 21: hypothetical solutions for neurodevelopmental models and therapeutic alternatives in down syndrome ,” Cell Biology International, vol. 40, no. 12, pp. 1256–1270, 2016. View at Publisher · View at Google Scholar
  • Oc-Hee Kim, Hyun-Ju Cho, Enna Han, Ted Inpyo Hong, Krishan Ariyasiri, Jung-Hwa Choi, Kyu-Seok Hwang, Yun-Mi Jeong, Se-Yeol Yang, Kweon Yu, Doo-Sang Park, Hyun-Woo Oh, Erica E. Davis, Charles E. Schwartz, Jeong-Soo Lee, Hyung-Goo Kim, and Cheol-Hee Kim, “Zebrafish knockout of Down syndrome gene, DYRK1A, shows social impairments relevant to autism,” Molecular Autism, vol. 8, no. 1, 2017. View at Publisher · View at Google Scholar
  • Alessandra Mozzi, Diego Forni, Rachele Cagliani, Uberto Pozzoli, Mario Clerici, and Manuela Sironi, “Distinct selective forces and Neanderthal introgression shaped genetic diversity at genes involved in neurodevelopmental disorders,” Scientific Reports, vol. 7, no. 1, 2017. View at Publisher · View at Google Scholar
  • Alexander M. Kleschevnikov, Jessica Yu, Jeesun Kim, Larisa V. Lysenko, Zheng Zhen, Y. Eugene Yu, and William C. Mobley, “Evidence that increased Kcnj6 gene dose is necessary for deficits in behavior and dentate gyrus synaptic plasticity in the Ts65Dn mouse model of Down syndrome,” Neurobiology of Disease, 2017. View at Publisher · View at Google Scholar
  • Yanyan Liu, Ziyuan Lin, Mingfeng Liu, He Wang, and Huaqin Sun, “Overexpression of DYRK1A, a Down Syndrome Candidate gene, Impairs Primordial Germ Cells Maintenance and Migration in zebrafish,” Scientific Reports, vol. 7, no. 1, 2017. View at Publisher · View at Google Scholar
  • Yann Herault, Jean M. Delabar, Elizabeth M. C. Fisher, Victor L. J. Tybulewicz, Eugene Yu, and Veronique Brault, “Rodent models in Down syndrome research: impact and future opportunities,” Disease Models & Mechanisms, vol. 10, no. 10, pp. 1165–1186, 2017. View at Publisher · View at Google Scholar